8-K filed June 27, 2024, 7:59 PM ET ticker ATER CIK 0001757715

other material confidence high sentiment positive materiality 0.75

Aterian raises Q2 revenue guidance, announces CEO change, appoints new CFO

Aterian, Inc.

Co-CEO Joe Risico resigns; Arturo Rodriguez appointed sole CEO; Josh Feldman named CFO.
Q2 2024 net revenue guidance raised to $23M-$26M from prior $20M-$23M.
Q2 2024 Adj. EBITDA loss range narrowed to -$1M to $0M from -$2M to -$1M.
Independent auditor changed: Deloitte dismissed (going concern emphasis), UHY appointed.

item 2.02 item 7.01 item 4.01 item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001437749-24-021429
form_type: 8-K
ticker: ATER
cik: 0001757715
company_name: Aterian, Inc.
filed_at: 2024-06-27T23:59:59+00:00
discovered_at: 2026-05-14T18:03:19.918418+00:00
generated_at: 2026-06-01T01:04:41.162890+00:00
sec_items: ["2.02", "7.01", "4.01", "5.02", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001437749-24-021429
json_url: https://secwatch.observer/filing/0001437749-24-021429.json
markdown_url: https://secwatch.observer/filing/0001437749-24-021429.md
text_url: https://secwatch.observer/filing/0001437749-24-021429.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1757715/000143774924021429/0001437749-24-021429-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1757715/000143774924021429/ater20240626_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Joseph Risico

Co-Chief Executive Officer

ATER · Aterian, Inc.

Effective: 2024-06-26
Filed: June 27, 2024, 7:59 PM ET

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Appointed

Josh Feldman

Chief Financial Officer

ATER · Aterian, Inc.

Effective: 2024-06-26
Successor: Arturo Rodriguez
Filed: June 27, 2024, 7:59 PM ET

The Company appointed Josh Feldman, age 47, to succeed Mr. Rodriguez as the Company’s Chief Financial Officer, effective June 26, 2024.

Role change

Arturo Rodriguez

Sole Chief Executive Officer

ATER · Aterian, Inc.

Effective: 2024-06-26
Filed: June 27, 2024, 7:59 PM ET

In connection with Mr. Risico’s resignation, the Board appointed Arturo Rodriguez the sole Chief Executive Officer of the Company and the sole principal executive officer.

Source-grounded claims

71d20c5d6b

Joseph Risico resigned as Co-Chief Executive Officer at Aterian, Inc..

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

7dc42108b1

Josh Feldman was appointed as Chief Financial Officer at Aterian, Inc..

The Company appointed Josh Feldman, age 47, to succeed Mr. Rodriguez as the Company’s Chief Financial Officer, effective June 26, 2024.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

c5b8a5a4ff

Arturo Rodriguez was appointed as Sole Chief Executive Officer at Aterian, Inc..

In connection with Mr. Risico’s resignation, the Board appointed Arturo Rodriguez the sole Chief Executive Officer of the Company and the sole principal executive officer.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 7.01, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).

Filing page SEC filing

ELOX

Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

Eloxx Pharmaceuticals, Inc. June 1, 2026, 7:00 AM ET other_material Items 3.02, 3.03, 5.03, 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board

Filing page SEC filing

FXAC

FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross

FortuneX Acquisition Corp May 29, 2026, 5:32 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.

Filing page SEC filing

CRMT

America's Car-Mart forms special committee for strategic alternatives; appoints new independent director

AMERICAS CARMART INC May 29, 2026, 5:30 PM ET other_material Items 1.01, 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.

Filing page SEC filing

MVST

Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs

Microvast Holdings, Inc. May 28, 2026, 5:26 PM ET other_material Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).

Filing page SEC filing

CWBHF

Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment

Charlotte's Web Holdings, Inc. June 1, 2026, 5:13 PM ET other_material Items 5.02, 5.07, 8.01

same fact type: executive_change same SEC item: 5.02 same event type: other_material similar materiality

This filing

On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.

Comparable filing

Effective May 28, 2026 (the “Effective Date”), the board of directors of Charlotte’s Web Holdings, Inc. (the “Company”), appoint James Jeffery Raborn to the Company’s board of directors

Filing page SEC filing

Source: SEC EDGAR

accession 0001437749-24-021429

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.